Skip to main content

Advertisement

SpringerLink
Log in

The WD40-Repeat Protein-Containing Deubiquitinase Complex: Catalysis, Regulation, and Potential for Therapeutic Intervention

  • Original Paper
  • Published:
Cell Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

Ubiquitination has emerged as an essential signaling mechanism in eukaryotes. Deubiquitinases (DUBs) counteract the activities of the ubiquitination machinery and provide another level of control in cellular ubiquitination. Not surprisingly, DUBs are subjected to stringent regulations. Besides regulation by the noncatalytic domains present in the DUB sequences, DUB-interacting proteins are increasingly realized as essential regulators for DUB activity and function. This review focuses on DUBs that are associated with WD40-repeat proteins. Many human ubiquitin-specific proteases (USPs) were found to interact with WD40-repeat proteins, but little is known as to how this interaction regulates the activity and function of USPs. In recent years, significant progress has been made in understanding a prototypical WD40-repeat protein-containing DUB complex that comprises USP1 and USP1-associated factor 1 (UAF1). It has been shown that UAF1 activates USP1 through a potential active-site modulation, and the complex formation between USP1 and UAF1 is regulated by serine phosphorylation. Recently, human USPs have been recognized as a promising target class for inhibitor discovery. Small molecule inhibitors targeting several human USPs have been reported. USP1 is involved in two major DNA damage response pathways, DNA translesion synthesis and the Fanconi anemia pathway. Inhibiting the USP1/UAF1 deubiquitinase complex represents a new strategy to potentiate cancer cells to DNA-crosslinking agents and to overcome resistance that has plagued clinical cancer chemotherapy. The progress in inhibitor discovery against USPs and the WD40-repeat protein-containing USP complex will be discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Komander, D. (2009). The emerging complexity of protein ubiquitination. Biochemical Society Transactions, 37, 937–953.

    Article  CAS  PubMed  Google Scholar 

  2. Pickart, C. M., & Eddins, M. J. (2004). Ubiquitin: structures, functions, mechanisms. Biochimica et Biophysica Acta, 1695, 55–72.

    Article  CAS  PubMed  Google Scholar 

  3. Pickart, C. M. (2001). Mechanisms underlying ubiquitination. Annual Review of Biochemistry, 70, 503–533.

    Article  CAS  PubMed  Google Scholar 

  4. Fang, S., & Weissman, A. M. (2004). A field guide to ubiquitylation. Cellular and Molecular Life Sciences, 61, 1546–1561.

    Article  CAS  PubMed  Google Scholar 

  5. van der Veen, A. G., & Ploegh, H. L. (2012). Ubiquitin-like proteins. Annual Review of Biochemistry, 81, 323–357.

    Article  PubMed  CAS  Google Scholar 

  6. Kirisako, T., Kamei, K., Murata, S., Kato, M., Fukumoto, H., Kanie, M., et al. (2006). A ubiquitin ligase complex assembles linear polyubiquitin chains. EMBO Journal, 25, 4877–4887.

    Article  CAS  PubMed  Google Scholar 

  7. Peng, J., Schwartz, D., Elias, J. E., Thoreen, C. C., Cheng, D., Marsischky, G., et al. (2003). A proteomics approach to understanding protein ubiquitination. Nature Biotechnology, 21, 921–926.

    Article  CAS  PubMed  Google Scholar 

  8. Xu, P., Duong, D. M., Seyfried, N. T., Cheng, D., Xie, Y., Robert, J., et al. (2009). Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell, 137, 133–145.

    Article  CAS  PubMed  Google Scholar 

  9. Iphofer, A., Kummer, A., Nimtz, M., Ritter, A., Arnold, T., Frank, R., et al. (2012). Profiling ubiquitin linkage specificities of deubiquitinating enzymes with branched ubiquitin isopeptide probes. Chembiochem: A European Journal of Chemical Biology, 13, 1416–1420.

    Article  CAS  Google Scholar 

  10. Kim, H. T., Kim, K. P., Lledias, F., Kisselev, A. F., Scaglione, K. M., Skowyra, D., et al. (2007). Certain pairs of ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s) synthesize nondegradable forked ubiquitin chains containing all possible isopeptide linkages. Journal of Biological Chemistry, 282, 17375–17386.

    Article  CAS  PubMed  Google Scholar 

  11. Chen, P. C., Na, C. H., & Peng, J. (2012). Quantitative proteomics to decipher ubiquitin signaling. Amino Acids, 43, 1049–1060.

    Article  CAS  PubMed  Google Scholar 

  12. Amerik, A. Y., & Hochstrasser, M. (2004). Mechanism and function of deubiquitinating enzymes. Biochimica et Biophysica Acta, 1695, 189–207.

    Article  CAS  PubMed  Google Scholar 

  13. Nijman, S. M., Luna-Vargas, M. P., Velds, A., Brummelkamp, T. R., Dirac, A. M., Sixma, T. K., et al. (2005). A genomic and functional inventory of deubiquitinating enzymes. Cell, 123, 773–786.

    Article  CAS  PubMed  Google Scholar 

  14. Komander, D., & Rape, M. (2012). The ubiquitin code. Annual Review of Biochemistry, 81, 203–229.

    Article  CAS  PubMed  Google Scholar 

  15. Fraile, J. M., Quesada, V., Rodriguez, D., Freije, J. M., & Lopez-Otin, C. (2012). Deubiquitinases in cancer: New functions and therapeutic options. Oncogene, 31, 2373–2388.

    Article  CAS  PubMed  Google Scholar 

  16. Hussain, S., Zhang, Y., & Galardy, P. J. (2009). DUBs and cancer: the role of deubiquitinating enzymes as oncogenes, non-oncogenes and tumor suppressors. Cell Cycle, 8, 1688–1697.

    Article  CAS  PubMed  Google Scholar 

  17. Ambroggio, X. I., Rees, D. C., & Deshaies, R. J. (2004). JAMM: a metalloprotease-like zinc site in the proteasome and signalosome. PLoS Biology, 2, E2.

    Article  PubMed  CAS  Google Scholar 

  18. Liang, J., Saad, Y., Lei, T., Wang, J., Qi, D., Yang, Q., et al. (2010). MCP-induced protein 1 deubiquitinates TRAF proteins and negatively regulates JNK and NF-kappaB signaling. Journal of Experimental Medicine, 207, 2959–2973.

    Article  CAS  PubMed  Google Scholar 

  19. Kessler, B. M., & Edelmann, M. J. (2011). PTMs in conversation: Activity and function of deubiquitinating enzymes regulated via post-translational modifications. Cell Biochemistry and Biophysics, 60, 21–38.

    Article  CAS  PubMed  Google Scholar 

  20. Reiley, W., Zhang, M., Wu, X., Granger, E., & Sun, S. C. (2005). Regulation of the deubiquitinating enzyme CYLD by IkappaB kinase gamma-dependent phosphorylation. Molecular and Cellular Biology, 25, 3886–3895.

    Article  CAS  PubMed  Google Scholar 

  21. Meray, R. K., & Lansbury, P. T, Jr. (2007). Reversible monoubiquitination regulates the Parkinson disease-associated ubiquitin hydrolase UCH-L1. Journal of Biological Chemistry, 282, 10567–10575.

    Article  CAS  PubMed  Google Scholar 

  22. Meulmeester, E., Kunze, M., Hsiao, H. H., Urlaub, H., & Melchior, F. (2008). Mechanism and consequences for paralog-specific sumoylation of ubiquitin-specific protease 25. Molecular Cell, 30, 610–619.

    Article  CAS  PubMed  Google Scholar 

  23. Todi, S. V., Winborn, B. J., Scaglione, K. M., Blount, J. R., Travis, S. M., & Paulson, H. L. (2009). Ubiquitination directly enhances activity of the deubiquitinating enzyme ataxin-3. EMBO Journal, 28, 372–382.

    Article  CAS  PubMed  Google Scholar 

  24. Huang, O. W., Ma, X., Yin, J., Flinders, J., Maurer, T., Kayagaki, N., et al. (2012). Phosphorylation-dependent activity of the deubiquitinase DUBA. Nature Structural and Molecular Biology, 19, 171–175.

    Article  CAS  PubMed  Google Scholar 

  25. Villamil, M. A., Liang, Q., Chen, J., Choi, Y. S., Hou, S., Lee, K. H., et al. (2012). Serine phosphorylation is critical for the activation of ubiquitin-specific protease 1 and its interaction with WD40-repeat protein UAF1. Biochemistry, 51(45), 9112–9123.

    Article  CAS  PubMed  Google Scholar 

  26. Dephoure, N., Zhou, C., Villen, J., Beausoleil, S. A., Bakalarski, C. E., Elledge, S. J., et al. (2008). A quantitative atlas of mitotic phosphorylation. Proceedings of the National Academy of Sciences of USA, 105, 10762–10767.

    Article  CAS  Google Scholar 

  27. Gauci, S., Helbig, A. O., Slijper, M., Krijgsveld, J., Heck, A. J., & Mohammed, S. (2009). Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach. Analytical Chemistry, 81, 4493–4501.

    Article  CAS  PubMed  Google Scholar 

  28. Matsuoka, S., Ballif, B. A., Smogorzewska, A., McDonald, E. R, 3rd, Hurov, K. E., Luo, J., et al. (2007). ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science, 316, 1160–1166.

    Article  CAS  PubMed  Google Scholar 

  29. Cotto-Rios, X. M., Jones, M. J., & Huang, T. T. (2011). Insights into phosphorylation-dependent mechanisms regulating USP1 protein stability during the cell cycle. Cell Cycle, 10, 4009–4016.

    Article  CAS  PubMed  Google Scholar 

  30. Sowa, M. E., Bennett, E. J., Gygi, S. P., & Harper, J. W. (2009). Defining the human deubiquitinating enzyme interaction landscape. Cell, 138, 389–403.

    Article  CAS  PubMed  Google Scholar 

  31. Stirnimann, C. U., Petsalaki, E., Russell, R. B., & Muller, C. W. (2010). WD40 proteins propel cellular networks. Trends in Biochemical Sciences, 35, 565–574.

    Article  CAS  PubMed  Google Scholar 

  32. Wall, M. A., Coleman, D. E., Lee, E., Iniguez-Lluhi, J. A., Posner, B. A., Gilman, A. G., et al. (1995). The structure of the G protein heterotrimer Gi alpha 1 beta 1 gamma 2. Cell, 83, 1047–1058.

    Article  CAS  PubMed  Google Scholar 

  33. Fong, H. K., Hurley, J. B., Hopkins, R. S., Miake-Lye, R., Johnson, M. S., Doolittle, R. F., et al. (1986). Repetitive segmental structure of the transducin beta subunit: Homology with the CDC4 gene and identification of related mRNAs. Proceedings of the National Academy of Sciences of USA, 83, 2162–2166.

    Article  CAS  Google Scholar 

  34. Neer, E. J., Schmidt, C. J., Nambudripad, R., & Smith, T. F. (1994). The ancient regulatory-protein family of WD-repeat proteins. Nature, 371, 297–300.

    Article  CAS  PubMed  Google Scholar 

  35. Paoli, M. (2001). Protein folds propelled by diversity. Progress in Biophysics and Molecular Biology, 76, 103–130.

    Article  CAS  PubMed  Google Scholar 

  36. Murzin, A. G. (1992). Structural principles for the propeller assembly of beta-sheets: The preference for seven-fold symmetry. Proteins, 14, 191–201.

    Article  CAS  PubMed  Google Scholar 

  37. Chen, C. K., Chan, N. L., & Wang, A. H. (2011). The many blades of the beta-propeller proteins: Conserved but versatile. Trends in Biochemical Sciences, 36, 553–561.

    Article  CAS  PubMed  Google Scholar 

  38. Xu, C., & Min, J. (2011). Structure and function of WD40 domain proteins. Protein and Cell, 2, 202–214.

    Article  CAS  PubMed  Google Scholar 

  39. Smith, T. F. (2008). Diversity of WD-repeat proteins. Sub-cellular Biochemistry, 48, 20–30.

    Article  PubMed  Google Scholar 

  40. Kipreos, E. T., & Pagano, M. (2000). The F-box protein family. Genome Biology, 1(5), REVIEWS3002.

    Article  CAS  PubMed  Google Scholar 

  41. Hart, M., Concordet, J. P., Lassot, I., Albert, I., del los Santos, R., Durand, H., et al. (1999). The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. Current Biology, 9, 207–210.

    Article  CAS  PubMed  Google Scholar 

  42. Liu, C., Kato, Y., Zhang, Z., Do, V. M., Yankner, B. A., & He, X. (1999). Beta-Trcp couples beta-catenin phosphorylation-degradation and regulates xenopus axis formation. Proceedings of the National Academy of Sciences USA, 96, 6273–6278.

    Article  CAS  Google Scholar 

  43. Kitagawa, M., Hatakeyama, S., Shirane, M., Matsumoto, M., Ishida, N., Hattori, K., et al. (1999). An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin. EMBO Journal, 18, 2401–2410.

    Article  CAS  PubMed  Google Scholar 

  44. Wu, G., Xu, G., Schulman, B. A., Jeffrey, P. D., Harper, J. W., & Pavletich, N. P. (2003). Structure of a beta-TrCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specificity of the SCF(beta-TrCP1) ubiquitin ligase. Molecular Cell, 11, 1445–1456.

    Article  CAS  PubMed  Google Scholar 

  45. Higa, L. A., Wu, M., Ye, T., Kobayashi, R., Sun, H., & Zhang, H. (2006). CUL4-DDB1 ubiquitin ligase interacts with multiple WD40-repeat proteins and regulates histone methylation. Nature Cell Biology, 8, 1277–1283.

    Article  CAS  PubMed  Google Scholar 

  46. Sims, R. J, 3rd, Nishioka, K., & Reinberg, D. (2003). Histone lysine methylation: A signature for chromatin function. Trends in Genetics (TIG), 19, 629–639.

    Article  CAS  Google Scholar 

  47. Wysocka, J., Swigut, T., Milne, T. A., Dou, Y., Zhang, X., Burlingame, A. L., et al. (2005). WDR5 associates with histone H3 methylated at K4 and is essential for H3 K4 methylation and vertebrate development. Cell, 121, 859–872.

    Article  CAS  PubMed  Google Scholar 

  48. Higa, L. A., Banks, D., Wu, M., Kobayashi, R., Sun, H., & Zhang, H. (2006). L2DTL/CDT2 interacts with the CUL4/DDB1 complex and PCNA and regulates CDT1 proteolysis in response to DNA damage. Cell Cycle, 5, 1675–1680.

    Article  CAS  PubMed  Google Scholar 

  49. Pashkova, N., Gakhar, L., Winistorfer, S. C., Yu, L., Ramaswamy, S., & Piper, R. C. (2010). WD40 repeat propellers define a ubiquitin-binding domain that regulates turnover of F box proteins. Molecular Cell, 40, 433–443.

    Article  CAS  PubMed  Google Scholar 

  50. Clague, M. J., Liu, H., & Urbe, S. (2012). Governance of endocytic trafficking and signaling by reversible ubiquitylation. Developmental Cell, 23, 457–467.

    Article  CAS  PubMed  Google Scholar 

  51. Clague, M. J., Coulson, J. M., & Urbe, S. (2012). Cellular functions of the DUBs. Journal of Cell Science, 125, 277–286.

    Article  CAS  PubMed  Google Scholar 

  52. Todi, S. V., & Paulson, H. L. (2011) Balancing act: Deubiquitinating enzymes in the nervous system. Trends in Neurosciences (in press).

  53. Nijman, S. M., Huang, T. T., Dirac, A. M., Brummelkamp, T. R., Kerkhoven, R. M., D’Andrea, A. D., et al. (2005). The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway. Molecular Cell, 17, 331–339.

    Article  CAS  PubMed  Google Scholar 

  54. Huang, T. T., Nijman, S. M., Mirchandani, K. D., Galardy, P. J., Cohn, M. A., Haas, W., et al. (2006). Regulation of monoubiquitinated PCNA by DUB autocleavage. Nature Cell Biology, 8, 339–347.

    CAS  PubMed  Google Scholar 

  55. Murai, J., Yang, K., Dejsuphong, D., Hirota, K., Takeda, S., & D’Andrea, A. D. (2011). The USP1/UAF1 complex promotes double-strand break repair through homologous recombination. Molecular and Cellular Biology, 31, 2462–2469.

    Article  CAS  PubMed  Google Scholar 

  56. Williams, S. A., Maecker, H. L., French, D. M., Liu, J., Gregg, A., Silverstein, L. B., et al. (2011). USP1 deubiquitinates ID proteins to preserve a mesenchymal stem cell program in osteosarcoma. Cell, 146, 918–930.

    Article  CAS  PubMed  Google Scholar 

  57. Nicassio, F., Corrado, N., Vissers, J. H., Areces, L. B., Bergink, S., Marteijn, J. A., et al. (2007). Human USP3 is a chromatin modifier required for S phase progression and genome stability. Current Biology, 17, 1972–1977.

    Article  CAS  PubMed  Google Scholar 

  58. Song, E. J., Werner, S. L., Neubauer, J., Stegmeier, F., Aspden, J., Rio, D., et al. (2010). The Prp19 complex and the Usp4Sart3 deubiquitinating enzyme control reversible ubiquitination at the spliceosome. Genes and Development, 24, 1434–1447.

    Article  CAS  PubMed  Google Scholar 

  59. Zhao, B., Schlesiger, C., Masucci, M. G., & Lindsten, K. (2009). The ubiquitin specific protease 4 (USP4) is a new player in the Wnt signalling pathway. Journal of Cellular and Molecular Medicine, 13, 1886–1895.

    Article  PubMed  Google Scholar 

  60. Li, M., Chen, D., Shiloh, A., Luo, J., Nikolaev, A. Y., Qin, J., et al. (2002). Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature, 416, 648–653.

    Article  CAS  PubMed  Google Scholar 

  61. Felle, M., Joppien, S., Nemeth, A., Diermeier, S., Thalhammer, V., Dobner, T., et al. (2011). The USP7/Dnmt1 complex stimulates the DNA methylation activity of Dnmt1 and regulates the stability of UHRF1. Nucleic Acids Research, 39, 8355–8365.

    Article  CAS  PubMed  Google Scholar 

  62. Saridakis, V., Sheng, Y., Sarkari, F., Holowaty, M. N., Shire, K., Nguyen, T., et al. (2005). Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization. Molecular Cell, 18, 25–36.

    Article  CAS  PubMed  Google Scholar 

  63. van der Horst, A., de Vries-Smits, A. M., Brenkman, A. B., van Triest, M. H., van den Broek, N., Colland, F., et al. (2006). FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP. Nature Cell Biology, 8, 1064–1073.

    Article  PubMed  CAS  Google Scholar 

  64. Sarkari, Feroz, Sheng, Yi, & Frappier, L. (2010). USP7/HAUSP promotes the sequence-specific DNA binding activity of p53. PLoS One, 5, e13040.

    Article  PubMed  CAS  Google Scholar 

  65. van der Knaap, J. A., Kumar, B. R., Moshkin, Y. M., Langenberg, K., Krijgsveld, J., Heck, A. J., et al. (2005). GMP synthetase stimulates histone H2B deubiquitylation by the epigenetic silencer USP7. Molecular Cell, 17, 695–707.

    Article  PubMed  CAS  Google Scholar 

  66. van der Knaap, J. A., Kozhevnikova, E., Langenberg, K., Moshkin, Y. M., & Verrijzer, C. P. (2010). Biosynthetic enzyme GMP synthetase cooperates with ubiquitin-specific protease 7 in transcriptional regulation of ecdysteroid target genes. Molecular and Cellular Biology, 30, 736–744.

    Article  PubMed  CAS  Google Scholar 

  67. Maertens, G. N., El Messaoudi-Aubert, S., Elderkin, S., Hiom, K., & Peters, G. (2010). Ubiquitin-specific proteases 7 and 11 modulate polycomb regulation of the INK4a tumour suppressor. The EMBO Journal, 29, 2553–2565.

    Article  CAS  PubMed  Google Scholar 

  68. Schoenfeld, A. R., Apgar, S., Dolios, G., Wang, R., & Aaronson, S. A. (2004). BRCA2 is ubiquitinated in vivo and interacts with USP11, a deubiquitinating enzyme that exhibits prosurvival function in the cellular response to DNA damage. Molecular and Cellular Biology, 24, 7444–7455.

    Article  CAS  PubMed  Google Scholar 

  69. Moretti, J., Chastagner, P., Liang, C. C., Cohn, M. A., Israel, A., & Brou, C. (2012). The ubiquitin-specific protease 12 (USP12) is a negative regulator of notch signaling acting on notch receptor trafficking toward degradation. The Journal of Biological Chemistry, 287, 29429–29441.

    Article  CAS  PubMed  Google Scholar 

  70. Joo, H. Y., Jones, A., Yang, C., Zhai, L., Smith, A. D. T., Zhang, Z., et al. (2011). Regulation of histone H2A and H2B deubiquitination and xenopus development by USP12 and USP46. The Journal of Biological Chemistry, 286, 7190–7201.

    Article  CAS  PubMed  Google Scholar 

  71. Kowalski, J. R., Dahlberg, C. L., & Juo, P. (2011). The deubiquitinating enzyme USP-46 negatively regulates the degradation of glutamate receptors to control their abundance in the ventral nerve cord of Caenorhabditis elegans. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 31, 1341–1354.

    Article  CAS  Google Scholar 

  72. Huang, X., Langelotz, C., Hetfeld-Pechoc, B. K., Schwenk, W., & Dubiel, W. (2009). The COP9 signalosome mediates beta-catenin degradation by deneddylation and blocks adenomatous polyposis coli destruction via USP15. Journal of Molecular Biology, 391, 691–702.

    Article  CAS  PubMed  Google Scholar 

  73. Hassink, G. C., Zhao, B., Sompallae, R., Altun, M., Gastaldello, S., Zinin, N. V., et al. (2009). The ER-resident ubiquitin-specific protease 19 participates in the UPR and rescues ERAD substrates. EMBO Reports, 10, 755–761.

    Article  CAS  PubMed  Google Scholar 

  74. Zhang, X.-Y., Pfeiffer, H. K., Thorne, A. W., & McMahon, S. B. (2008). USP22, an hSAGA subunit and potential cancer stem cell marker, reverses the polycomb-catalyzed ubiquitylation of histone H2A. Cell Cycle, 7, 1522–1524.

    Article  CAS  PubMed  Google Scholar 

  75. Zhu, P., Zhou, W., Wang, J., Puc, J., Ohgi, K. A., Erdjument-Bromage, H., et al. (2007). A histone H2A deubiquitinase complex coordinating histone acetylation and H1 dissociation in transcriptional regulation. Molecular Cell, 27, 609–621.

    Article  CAS  PubMed  Google Scholar 

  76. Zhao, Y., Lang, G., Ito, S., Bonnet, J., Metzger, E., Sawatsubashi, S., et al. (2008). A TFTC/STAGA module mediates histone H2A and H2B deubiquitination, coactivates nuclear receptors, and counteracts heterochromatin silencing. Molecular Cell, 29, 92–101.

    Article  CAS  PubMed  Google Scholar 

  77. Taillebourg, E., Gregoire, I., Viargues, P., Jacomin, A. C., Thevenon, D., Faure, M., et al. (2012). The deubiquitinating enzyme USP36 controls selective autophagy activation by ubiquitinated proteins. Autophagy, 8, 767–779.

    Article  CAS  PubMed  Google Scholar 

  78. Richardson, L. A., Reed, B. J., Charette, J. M., Freed, E. F., Fredrickson, E. K., Locke, M. N., et al. (2012). A conserved deubiquitinating enzyme controls cell growth by regulating RNA polymerase I stability. Cell Reports, 2, 372–385.

    Article  CAS  PubMed  Google Scholar 

  79. Yang, W. C., & Shih, H. M. (2012). The deubiquitinating enzyme USP37 regulates the oncogenic fusion protein PLZF/RARA stability. Oncogene,. doi:10.1038/onc.2012.537.

    Google Scholar 

  80. van Leuken, Renske J., Luna-Vargas, Mark P., Sixma, Titia K., Wolthuis, R. M. F., & Medema, R. H. (2008). Usp39 is essential for mitotic spindle checkpoint integrity and controls mRNA-levels of aurora B. Cell Cycle, 7, 2710–2719.

    Article  PubMed  Google Scholar 

  81. Hock, A. K., Vigneron, A. M., Carter, S., Ludwig, R. L., & Vousden, K. H. (2011). Regulation of p53 stability and function by the deubiquitinating enzyme USP42. The EMBO Journal, 30, 4921–4930.

    Article  CAS  PubMed  Google Scholar 

  82. Jeandidier, E., Gervais, C., Radford-Weiss, I., Zink, E., Gangneux, C., Eischen, A., et al. (2012). A cytogenetic study of 397 consecutive acute myeloid leukemia cases identified three with a t(7, 21) associated with 5q abnormalities and exhibiting similar clinical and biological features, suggesting a new, rare acute myeloid leukemia entity. Cancer Genetics, 205, 365–372.

    Article  CAS  PubMed  Google Scholar 

  83. Giguere, A., & Hebert, J. (2011). Microhomologies and topoisomerase II consensus sequences identified near the breakpoint junctions of the recurrent t(7, 21)(p22;q22) translocation in acute myeloid leukemia. Genes, Chromosomes and Cancer, 50, 228–238.

    CAS  PubMed  Google Scholar 

  84. Fuchs, G., Shema, E., Vesterman, R., Kotler, E., Wolchinsky, Z., Wilder, S., et al. (2012). RNF20 and USP44 regulate stem cell differentiation by modulating H2B monoubiquitylation. Molecular Cell, 46, 662–673.

    Article  CAS  PubMed  Google Scholar 

  85. Zhang, Y., Foreman, O., Wigle, D. A., Kosari, F., Vasmatzis, G., Salisbury, J. L., et al. (2012). USP44 regulates centrosome positioning to prevent aneuploidy and suppress tumorigenesis. The Journal of Clinical Investigation, 122, 4362–4374.

    Article  CAS  PubMed  Google Scholar 

  86. Tomida, S., Mamiya, T., Sakamaki, H., Miura, M., Aosaki, T., Masuda, M., et al. (2009). Usp46 is a quantitative trait gene regulating mouse immobile behavior in the tail suspension and forced swimming tests. Nature Genetics, 41, 688–695.

    Article  CAS  PubMed  Google Scholar 

  87. Zhang, W., Tian, Q. B., Li, Q. K., Wang, J. M., Wang, C. N., Liu, T., et al. (2011). Lysine 92 amino acid residue of USP46, a gene associated with ‘behavioral despair’ in mice, influences the deubiquitinating enzyme activity. PLoS One, 6, e26297.

    Article  CAS  PubMed  Google Scholar 

  88. Parsons, J. L., Dianova, I. I., Khoronenkova, S. V., Edelmann, M. J., Kessler, B. M., & Dianov, G. L. (2011). USP47 is a deubiquitylating enzyme that regulates base excision repair by controlling steady-state levels of DNA polymerase beta. Molecular Cell, 41, 609–615.

    Article  CAS  PubMed  Google Scholar 

  89. Peschiaroli, A., Skaar, J. R., Pagano, M., & Melino, G. (2010). The ubiquitin-specific protease USP47 is a novel beta-TRCP interactor regulating cell survival. Oncogene, 29, 1384–1393.

    Article  CAS  PubMed  Google Scholar 

  90. Aressy, B., Jullien, D., Cazales, M., Marcellin, M., Bugler, B., Burlet-Schiltz, O., et al. (2010). A screen for deubiquitinating enzymes involved in the G(2)/M checkpoint identifies USP50 as a regulator of HSP90-dependent Wee1 stability. Cell Cycle, 9, 3815–3822.

    Article  CAS  PubMed  Google Scholar 

  91. Inui, M., Manfrin, A., Mamidi, A., Martello, G., Morsut, L., Soligo, S., et al. (2011). USP15 is a deubiquitylating enzyme for receptor-activated SMADs. Nature Cell Biology, 13, 1368–1375.

    Article  CAS  PubMed  Google Scholar 

  92. Cohn, M. A., Kee, Y., Haas, W., Gygi, S. P., & D’Andrea, A. D. (2009). UAF1 Is a subunit of multiple deubiquitinating enzyme complexes. Journal of Biological Chemistry, 284, 5343–5351.

    Article  CAS  PubMed  Google Scholar 

  93. Kee, Y., Yang, K. L., Cohn, M. A., Haas, W., Gygi, S. P., & D’Andrea, A. D. (2010). WDR20 regulates activity of the USP12 center dot UAF1 deubiquitinating enzyme complex. Journal of Biological Chemistry, 285, 11252–11257.

    Article  CAS  PubMed  Google Scholar 

  94. Sims, A. E., Spiteri, E., Sims, R. J, 3rd, Arita, A. G., Lach, F. P., Landers, T., et al. (2007). FANCI is a second monoubiquitinated member of the Fanconi anemia pathway. Nature Structural and Molecular Biology, 14, 564–567.

    Article  CAS  PubMed  Google Scholar 

  95. Smogorzewska, A., Matsuoka, S., Vinciguerra, P., McDonald, E. R, 3rd, Hurov, K. E., Luo, J., et al. (2007). Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell, 129, 289–301.

    Article  CAS  PubMed  Google Scholar 

  96. D’Andrea, A. D. (2003). The Fanconi road to cancer. Genes and Development, 17, 1933–1936.

    Article  PubMed  CAS  Google Scholar 

  97. Wang, W. (2007). Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nature Reviews Genetics, 8, 735–748.

    Article  CAS  PubMed  Google Scholar 

  98. Grompe, M., & van de Vrugt, H. (2007). The Fanconi family adds a fraternal twin. Developmental Cell, 12, 661–662.

    Article  CAS  PubMed  Google Scholar 

  99. Taniguchi, T., Garcia-Higuera, I., Andreassen, P. R., Gregory, R. C., Grompe, M., & D’Andrea, A. D. (2002). S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood, 100, 2414–2420.

    Article  CAS  PubMed  Google Scholar 

  100. Wang, X., Andreassen, P. R., & D’Andrea, A. D. (2004). Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin. Molecular and Cellular Biology, 24, 5850–5862.

    Article  CAS  PubMed  Google Scholar 

  101. Kim, H., & D’Andrea, A. D. (2012). Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway. Genes and Development, 26, 1393–1408.

    Article  CAS  PubMed  Google Scholar 

  102. Crossan, G. P., & Patel, K. J. (2012). The Fanconi anaemia pathway orchestrates incisions at sites of crosslinked DNA. The Journal of Pathology, 226, 326–337.

    Article  CAS  PubMed  Google Scholar 

  103. Oestergaard, V. H., Langevin, F., Kuiken, H. J., Pace, P., Niedzwiedz, W., Simpson, L. J., et al. (2007). Deubiquitination of FANCD2 is required for DNA crosslink repair. Molecular Cell, 28, 798–809.

    Article  CAS  PubMed  Google Scholar 

  104. Chen, J., Bozza, W., & Zhuang, Z. (2011). Ubiquitination of PCNA and its essential role in eukaryotic translesion synthesis. Cell Biochemistry and Biophysics, 60, 47–60.

    Article  PubMed  CAS  Google Scholar 

  105. Hoege, C., Pfander, B., Moldovan, G.-L., Pyrowolakis, G., & Jentsch, S. (2002). RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature, 419, 135–141.

    Article  CAS  PubMed  Google Scholar 

  106. Stelter, P., & Ulrich, H. D. (2003). Control of spontaneous and damage- induced mutagenesis by SUMO and ubiquitin conjugation. Nature, 425, 188–191.

    Article  CAS  PubMed  Google Scholar 

  107. Zhuang, Z., Johnson, R. E., Haracska, L., Prakash, L., Prakash, S., & Benkovic, S. J. (2008). Regulation of polymerase exchange between Poleta and Poldelta by monoubiquitination of PCNA and the movement of DNA polymerase holoenzyme. Proceedings of the National Academy of Sciences USA, 105, 5361–5366.

    Article  CAS  Google Scholar 

  108. Watanabe, K., Tateishi, S., Kawasuji, M., Tsurimoto, T., Inoue, H., & Yamaizumi, M. (2004). Rad18 guides polg to replication stalling sites through physical interaction and PCNA monoubiquitination. The EMBO Journal, 23, 3886–3896.

    Article  CAS  PubMed  Google Scholar 

  109. Kannouche, P. (2001). Domain structure, localization, and function of DNA polymerase eta, defective in xeroderma pigmentosum variant cells. Genes and Development, 15, 158–172.

    Article  CAS  PubMed  Google Scholar 

  110. Juhasz, S., Balogh, D., Hajdu, I., Burkovics, P., Villamil, M. A., Zhuang, Z., et al. (2012). Characterization of human Spartan/C1orf124, an ubiquitin-PCNA interacting regulator of DNA damage tolerance. Nucleic Acids Research, 40, 10795–10808.

    Article  CAS  PubMed  Google Scholar 

  111. Haracska, L., Torres-Ramos, C. A., Johnson, R. E., Prakash, S., & Prakash, L. (2004). Opposing effects of ubiquitin conjugation and SUMO modification of PCNA on replicational bypass of DNA lesions in Saccharomyces cerevisiae. Molecular and Cellular Biology, 24, 4267–4274.

    Article  CAS  PubMed  Google Scholar 

  112. Brown, S., Niimi, A., & Lehmann, A. R. (2009). Ubiquitination and deubiquitination of PCNA in response to stalling of the replication fork. Cell Cycle, 8, 689–692.

    Article  CAS  PubMed  Google Scholar 

  113. Lee, K. Y., Yang, K., Cohn, M. A., Sikdar, N., D’Andrea, A. D., & Myung, K. (2010). Human ELG1 regulates the level of ubiquitinated proliferating cell nuclear antigen (PCNA) through its interactions with PCNA and USP1. Journal of Biological Chemistry, 285, 10362–10369.

    Article  CAS  PubMed  Google Scholar 

  114. Fox, J. T., Lee, K. Y., & Myung, K. (2011). Dynamic regulation of PCNA ubiquitylation/deubiquitylation. FEBS Letters, 585, 2780–2785.

    Article  CAS  PubMed  Google Scholar 

  115. Jones, M. J., Colnaghi, L., & Huang, T. T. (2012). Dysregulation of DNA polymerase kappa recruitment to replication forks results in genomic instability. The EMBO Journal, 31, 908–918.

    Article  CAS  PubMed  Google Scholar 

  116. Kim, J. M., Parmar, K., Huang, M., Weinstock, D. M., Ruit, C. A., Kutok, J. L., et al. (2009). Inactivation of murine Usp1 results in genomic instability and a Fanconi anemia phenotype. Developmental Cell, 16, 314–320.

    Article  CAS  PubMed  Google Scholar 

  117. Chen, J., Dexheimer, T. S., Ai, Y., Liang, Q., Villamil, M. A., Inglese, J., et al. (2011). Selective and cell-active inhibitors of the USP1/UAF1 deubiquitinase complex reverse cisplatin resistance in non-small cell lung cancer cells. Chemistry and Biology, 18, 1390–1400.

    Article  CAS  PubMed  Google Scholar 

  118. Cohn, M. A., Kowal, P., Yang, K., Haas, W., Huang, T. T., Gygi, S. P., et al. (2007). A UAF1-containing multisubunit protein complex regulates the Fanconi anemia pathway. Molecular Cell, 28, 786–797.

    Article  CAS  PubMed  Google Scholar 

  119. Villamil, M. A., Chen, J., Liang, Q., & Zhuang, Z. (2012). A noncanonical cysteine protease USP1 is activated through active site modulation by USP1-associated factor 1. Biochemistry, 51, 2829–2839.

    Article  CAS  PubMed  Google Scholar 

  120. Bounpheng, M. A., Dimas, J. J., Dodds, S. G., & Christy, B. A. (1999). Degradation of Id proteins by the ubiquitin-proteasome pathway. Faseb Journal, 13, 2257–2264.

    CAS  PubMed  Google Scholar 

  121. Imai, S., Mamiya, T., Tsukada, A., Sakai, Y., Mouri, A., Nabeshima, T., et al. (2012). Ubiquitin-specific peptidase 46 (Usp46) regulates mouse immobile behavior in the tail suspension test through the GABAergic system. PLoS One, 7, e39084.

    Article  CAS  PubMed  Google Scholar 

  122. Luna-Vargas, M. P., Faesen, A. C., van Dijk, W. J., Rape, M., Fish, A., & Sixma, T. K. (2011). Ubiquitin-specific protease 4 is inhibited by its ubiquitin-like domain. EMBO Reports, 12, 365–372.

    Article  CAS  PubMed  Google Scholar 

  123. Ye, Y., Scheel, H., Hofmann, K., & Komander, D. (2009). Dissection of USP catalytic domains reveals five common insertion points. Molecular BioSystems, 5, 1797–1808.

    Article  CAS  PubMed  Google Scholar 

  124. Renatus, M., Parrado, S. G., D’Arcy, A., Eidhoff, U., Gerhartz, B., Hassiepen, U., et al. (2006). Structural basis of ubiquitin recognition by the deubiquitinating protease USP2. Structure, 14, 1293–1302.

    Article  CAS  PubMed  Google Scholar 

  125. Hu, M., Li, P., Li, M., Li, W., Yao, T., Wu, J.-W., et al. (2002). Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell, 111, 1041–1054.

    Article  CAS  PubMed  Google Scholar 

  126. Avvakumov, G. V., Walker, J. R., Xue, S., Finerty, P. J, Jr, Mackenzie, F., Newman, E. M., et al. (2006). Amino-terminal dimerization, NRDP1-rhodanese interaction, and inhibited catalytic domain conformation of the ubiquitin-specific protease 8 (USP8). The Journal of Biological Chemistry, 281, 38061–38070.

    Article  CAS  PubMed  Google Scholar 

  127. Hu, M., Li, P., Song, L., Jeffrey, P. D., Chernova, T. A., Wilkinson, K. D., et al. (2005). Structure and mechanisms of the proteasome- associated deubiquitinating enzyme USP14. The EMBO Journal, 24, 3747–3756.

    Article  CAS  PubMed  Google Scholar 

  128. Ye, Y., Akutsu, M., Reyes-Turcu, F., Enchev, R. I., Wilkinson, K. D., & Komander, D. (2011). Polyubiquitin binding and cross-reactivity in the USP domain deubiquitinase USP21. EMBO Reports, 12, 350–357.

    Article  CAS  PubMed  Google Scholar 

  129. Zhang, W., Sulea, T., Tao, L., Cui, Q., Purisima, E. O., Vongsamphanh, R., et al. (2011). Contribution of active site residues to substrate hydrolysis by USP2: Insights into catalysis by ubiquitin specific proteases. Biochemistry, 50, 4775–4785.

    Article  CAS  PubMed  Google Scholar 

  130. Samara, N. L., Datta, A. B., Berndsen, C. E., Zhang, X., Yao, T., Cohen, R. E., et al. (2010). Structural insights into the assembly and function of the SAGA deubiquitinating module. Science, 328, 1025–1029.

    Article  CAS  PubMed  Google Scholar 

  131. Wilson, M. A., Koutelou, E., Hirsch, C., Akdemir, K., Schibler, A., Barton, M. C., et al. (2011). Ubp8 and SAGA regulate Snf1 AMP kinase activity. Molecular and Cellular Biology, 31, 3126–3135.

    Article  CAS  PubMed  Google Scholar 

  132. Lee, K. K., Florens, L., Swanson, S. K., Washburn, M. P., & Workman, J. L. (2005). The deubiquitylation activity of Ubp8 is dependent upon Sgf11 and its association with the SAGA complex. Molecular and Cellular Biology, 25, 1173–1182.

    Article  CAS  PubMed  Google Scholar 

  133. Faesen, A. C., Dirac, A. M., Shanmugham, A., Ovaa, H., Perrakis, A., & Sixma, T. K. (2011). Mechanism of USP7/HAUSP activation by its C-terminal ubiquitin-like domain and allosteric regulation by GMP-synthetase. Molecular Cell, 44, 147–159.

    Article  CAS  PubMed  Google Scholar 

  134. Singhal, S., Taylor, M. C., & Baker, R. T. (2008). Deubiquitylating enzymes and disease. BMC Biochemistry, 9(Suppl 1), S3.

    Article  PubMed  CAS  Google Scholar 

  135. Colland, F. (2010). The therapeutic potential of deubiquitinating enzyme inhibitors. Biochemical Society Transactions, 38, 137–143.

    Article  CAS  PubMed  Google Scholar 

  136. D’Arcy, P., Brnjic, S., Olofsson, M. H., Fryknas, M., Lindsten, K., De Cesare, M., et al. (2011). Inhibition of proteasome deubiquitinating activity as a new cancer therapy. Nature Medicine, 17, 1636–1640.

    Article  PubMed  CAS  Google Scholar 

  137. Colland, F., Formstecher, E., Jacq, X., Reverdy, C., Planquette, C., Conrath, S., et al. (2009). Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells. Molecular Cancer Therapeutics, 8, 2286–2295.

    Article  CAS  PubMed  Google Scholar 

  138. Reverdy, C., Conrath, S., Lopez, R., Planquette, C., Atmanene, C., Collura, V., et al. (2012). Discovery of specific inhibitors of human USP7/HAUSP deubiquitinating enzyme. Chemistry and Biology, 19, 467–477.

    Article  CAS  PubMed  Google Scholar 

  139. Tian, X., Isamiddinova, N. S., Peroutka, R. J., Goldenberg, S. J., Mattern, M. R., Nicholson, B., et al. (2011). Characterization of selective ubiquitin and ubiquitin-like protease inhibitors using a fluorescence-based multiplex assay format. Assay and Drug Development Technologies, 9, 165–173.

    Article  CAS  PubMed  Google Scholar 

  140. Liu, J., Xia, H., Kim, M., Xu, L., Li, Y., Zhang, L., et al. (2011). Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13. Cell, 147, 223–234.

    Article  CAS  PubMed  Google Scholar 

  141. Lee, B. H., Lee, M. J., Park, S., Oh, D. C., Elsasser, S., Chen, P. C., et al. (2010). Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature, 467, 179–184.

    Article  CAS  PubMed  Google Scholar 

  142. Weinstock, J., Wu, J., Cao, P., Kingsbury, W. D., McDermott, J. L., Kodrasov, M. P., et al. (2012). Selective dual inhibitors of the cancer-related deubiquitylating proteases USP7 and USP47. ACS Medicinal Chemistry Letters, 3, 789–792.

    Article  CAS  Google Scholar 

  143. Chauhan, D., Tian, Z., Nicholson, B., Kumar, K. G., Zhou, B., Carrasco, R., et al. (2012). A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance. Cancer Cell, 22, 345–358.

    Article  CAS  PubMed  Google Scholar 

  144. Schuster-Bockler, B., Schultz, J., & Rahmann, S. (2004). HMM Logos for visualization of protein families. BMC Bioinformatics, 5, 7.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by a grant from the US National Institutes of Health to Z. Zhuang (R01GM097468).

Author information

Authors and Affiliations

  1. Department of Chemistry and Biochemistry, University of Delaware, 214A Drake Hall, Newark, DE, 19716, USA

    Mark A. Villamil, Qin Liang & Zhihao Zhuang

Authors
  1. Mark A. Villamil
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Qin Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhihao Zhuang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhihao Zhuang.

Additional information

Mark A. Villamil and Qin Liang contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Villamil, M.A., Liang, Q. & Zhuang, Z. The WD40-Repeat Protein-Containing Deubiquitinase Complex: Catalysis, Regulation, and Potential for Therapeutic Intervention. Cell Biochem Biophys 67, 111–126 (2013). https://doi.org/10.1007/s12013-013-9637-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-013-9637-1

Keywords

Search

Navigation